ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1889

Rheumatoid Arthritis (RA)-Associated Risk Allele LBH Alters the Function of a Differentially Methylated LBH Enhancer

Deepa Hammaker1, Gary S. Firestein2, Wei Wang3, John W. Whitaker4 and Anna-Karin Ekwall5, 1Medicine, University of California San Diego, La Jolla, CA, 2Division of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, CA, 3Chemistry, UCSD, La Jolla, CA, 4860 island ave, UCSD, San Diego, CA, 5Medicine, UC San Diego, La Jolla, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Epigenetics, methylation and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics, Genomics and Proteomics I: Epigenetic Mechanisms in Autoimmunity

Session Type: Abstract Submissions (ACR)

Background/Purpose

Recent data suggest that epigenetics, including DNA methylation, contributes to imprinting RA fibroblast-like synoviocytes (FLS) and alters their behavior. To understand how RA-associated risk alleles and differential methylation affect cis-regulatory regions, we compared differentially methylated loci (DML) in RA FLS with fibroblast DNase I hypersensitive sites. The differentially methylated enhancers (DMEs) were then integrated with RA-associated SNPs to identify key regulatory sites. In this study, we found and characterized an RA-associated SNP that colocalized with a DME in a key cancer-related gene that regulates cell growth and differentiation, namely limb-bud and heart development (LBH).

Methods

15,220 RA-associated DMLs identified using Illumina 450k chips from 11 RA and 11 OA FLS were integrated with DNase I hypersensitive sites in the ENCODE database for 125 cell-types/conditions, including lung fibroblasts. These DMEs were then compared with GWAS data. Genomic DNA was isolated and the 1.4kb region with the WT allele (G) or RA SNP (T) of lbh was cloned into minimal promoter pGL4.23-luciferase construct.  For methylation studies, plasmids were methylated with the CpG-methyltransferase M.SssI and S-adenosyl methionine.  Methylation of all CpGs was verified by bisulfite modification and pyrosequencing.  The WT, RA SNP or control plasmids (1ug) were transfected into cultured RA FLS by nucleofection with Renilla construct.  Firefly luciferase activity was normalized to renilla.

Results

A DNase I hypersensitive site that is hypomethylated in RA FLS was identified in a 1400 bp region upstream of the LBH gene transcription start site. An RA and SLE-associated SNP (rs906868, G/T) was identified in the same region. We first determined the transcription differences between the WT and RA SNP in transfected RA FLS. Surprisingly, luciferase activity was significantly decreased in the WT group compared with the RA SNP (19±7%, p=0.02, n=9 lines), suggesting that the regulatory region decreases gene expression in WT cells. The RA SNP had no effect on luciferase expression compared with control. We then evaluated whether CpG methylation of the plasmids altered function of the enhancer region.  Methylation of the RA SNP plasmid significantly decreased the luciferase activity by 46±4% compared with the unmethylated (p=0.0005, n=5 lines). In contrast, methylation increased the luciferase activity in the WT group (42±17%, p=0.049, n=5 lines) but not in the control group.

Conclusion

We identified a novel candidate regulatory region by integrating ENCODE with RA GWAS and RA DNA methylation databases. The RA-associated allele in lbh eliminated its regulatory function. This is the first demonstration that an RA risk allele in a regulatory region has functional effects. By altering enhancer function of a gene that is intimately involved with cell proliferation (LBH), the risk allele could contribute to the aggressive behavior of RA FLS. Furthermore, the functional effects of methylation are distinctly different between RA-associated alleles and WT. These data provide evidence that combinations of epigenetic and risk allele data can provide new clues to the pathogenesis of RA.


Disclosure:

D. Hammaker,
None;

G. S. Firestein,
None;

W. Wang,
None;

J. W. Whitaker,
None;

A. K. Ekwall,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rheumatoid-arthritis-ra-associated-risk-allele-lbh-alters-the-function-of-a-differentially-methylated-lbh-enhancer/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology